These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 826103)

  • 1. [Single weekly doses of 1 mg 1-thyroxine for the treatment of mild goiter and for the prevention of recurrence after goiter surgery].
    Bauhofer G; Hugl H; Zechmann W; Riccabona G
    Acta Med Austriaca; 1976; 3(2):54-8. PubMed ID: 826103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial target organ resistance to thyroid hormone.
    Bode HH; Danon M; Weintraub BD; Maloof F; Crawford JD
    J Clin Invest; 1973 Apr; 52(4):776-82. PubMed ID: 4632689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thyroxine in the treatment of euthyroid goiter and the prevention of goiter recurrence].
    Goebel R; Leb G; Pohl P; Haralambus I; Warnkross H
    Acta Med Austriaca; 1976; 3(3):78-80. PubMed ID: 826506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial partial peripheral and pituitary resistance to thyroid hormone: a frequently missed diagnosis?
    Hopwood NJ; Saunder SE; Shapiro B; Sisson JC
    Pediatrics; 1986 Dec; 78(6):1114-22. PubMed ID: 3097618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intramuscular thyrotropin-releasing hormone on the thyroid 131I uptake in man.
    Azizi F; Vagenakis AG; Braverman LE
    Johns Hopkins Med J; 1975 Jan; 136(1):11-4. PubMed ID: 805310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of the TSH level in thyroidectomized patients after thyrotropin releasing hormone (TRH)].
    Piaszek L; Strötges MW
    Nucl Med (Stuttg); 1976 Feb; 15(1):43-5. PubMed ID: 815889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of the optimal L-thyroxine dosage for treating nontoxic goiter].
    Biersack HJ; Albrecht W; Oehr P; Rasche A; Winkler C
    Dtsch Med Wochenschr; 1983 Aug; 108(34):1269-73. PubMed ID: 6411440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is routine thyroxine treatment to hinder postoperative recurrence of nontoxic goiter justified?
    Hegedüs L; Nygaard B; Hansen JM
    J Clin Endocrinol Metab; 1999 Feb; 84(2):756-60. PubMed ID: 10022449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.
    Huysmans DA; Nieuwlaat WA; Erdtsieck RJ; Schellekens AP; Bus JW; Bravenboer B; Hermus AR
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3592-6. PubMed ID: 11061507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pituitary-thyroid axis after hemithyroidectomy in euthyroid man.
    Matte R; Ste-Marie LG; Comtois R; D'Amour P; Lacroix A; Chartrand R; Poisson R; Bastomsky CH
    J Clin Endocrinol Metab; 1981 Aug; 53(2):377-80. PubMed ID: 6788794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRH test as an index of suppression compared with the thyroid radioiodine uptake in euthyroid goitrous patients treated with thyroxine.
    Krugman LG; Hershman JM
    J Clin Endocrinol Metab; 1978 Jul; 47(1):78-83. PubMed ID: 122398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of autonomy in idiopathic non-toxic goiter, evaluated by regional suppressibility of 99mTc-uptake and TSH response to TRH.
    Dige-Petersen H; Clemmensen OJ; Hummer L
    Nuklearmedizin; 1976 Aug; 15(4):197-200. PubMed ID: 824625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thyroidal T4/T3 ratio and its regulation in non-toxic goitre.
    Reinwein D; Durrer HA; Wiermann H; Löhnert J; von zur Mühlen A
    Horm Metab Res; 1976 Sep; 8(5):394-9. PubMed ID: 824192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function of the thyroid gland after subtotal resection for hyperthyroidism in relation to remnant size.
    Gillquist J; Lundström B; Kågedal B
    Acta Chir Scand; 1977; 143(2):95-9. PubMed ID: 409016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical hyperthyroidism in multinodular goiter.
    Gemsenjäger E; Staub JJ; Girard J; Heitz P
    J Clin Endocrinol Metab; 1976 Oct; 43(4):810-6. PubMed ID: 61970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effectiveness of recurrence prophylaxis four to five years after struma surgery].
    Weber MJ; Hefti E; Wetz B; Kinser J
    Helv Chir Acta; 1980 Jun; 47(1-2):7-10. PubMed ID: 6777335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thyroxine vs iodine and thyroxine. Comparison of the TSH suppression test].
    Kahaly G; Mihaljevic V; Beyer J; Krause U
    Schweiz Med Wochenschr; 1989 Jan; 119(2):59-64. PubMed ID: 2492674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.